AMY SHARRON: Open Payments
NPI 1861551707 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$238 in 12 payments from 8 companies in 2025. Trend: 2023 $651 · 2024 $83 · 2025 $238
Food & beverage: $238
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $79 |
| Incyte Corporation | 2 | $39 |
| Rigel Pharmaceuticals, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $23 |
| Alkermes, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $15 |
Products named: FANAPT, JAKAFI, TAVALISSE, VENCLEXTA, ARISTADA, KEYTRUDA, Mirena, REXULTI.
Industry payments across MA — which companies pay providers there.
